247 related articles for article (PubMed ID: 30837537)
1. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
[TBL] [Abstract][Full Text] [Related]
2. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
3. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.
Prasitsuebsai W; Kariminia A; Puthanakit T; Lumbiganon P; Hansudewechakul R; Siew Moy F; Law M; Kumarasamy N; Razali K; Sirisanthana V; Sohn AH; Chokephaibulkit K
Pediatr Infect Dis J; 2014 Jul; 33(7):747-52. PubMed ID: 24378942
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
Arefaine ZG; Abebe S; Bekele E; Adem A; Adama Y; H Brockmeyer N; Coenenberg J; Potthoff A; Gebremeskel TG
PLoS One; 2020; 15(4):e0229757. PubMed ID: 32310961
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
[TBL] [Abstract][Full Text] [Related]
6. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic infections in relation to antiretroviral status among AIDS patients from south India.
Srirangaraj S; Venkatesha D
Indian J Med Microbiol; 2011; 29(4):395-400. PubMed ID: 22120801
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
10. Treatment of opportunistic infections prior to HAART initiation does not affect immune reconstitution in HIV-infected patients.
Pornprasert S; Traisathit P; Singboottra P; Huong NN
Curr HIV Res; 2012 Oct; 10(7):592-6. PubMed ID: 22973852
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic infections: an update.
Furrer H; Fux C
J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular diseases in a nationwide HIV/AIDS patient cohort in Taiwan from 2000 to 2014.
Lai YJ; Chen YY; Huang HH; Ko MC; Chen CC; Yen YF
Epidemiol Infect; 2018 Dec; 146(16):2066-2071. PubMed ID: 30157970
[TBL] [Abstract][Full Text] [Related]
14. Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
Núñez M; Asencio R; Valencia ME; Leal M; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2003 May; 19(5):363-8. PubMed ID: 12803995
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
Dembelu M; Kote M; Gilano G; Mohammed T
PLoS One; 2021; 16(12):e0261454. PubMed ID: 34972122
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis and treatment of opportunistic infection in patients on HAART.
Tantisiriwat W; Powderly WG
AIDS Read; 1999; 9(2):122-30. PubMed ID: 12728894
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
19. Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.
Zhou F; Kominski GF; Qian HZ; Wang J; Duan S; Guo Z; Zhao X
BMC Med; 2011 Jan; 9():6. PubMed ID: 21241494
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
